EUVIMEDEUVIMED entdecken
Crossref

Computational Drug Repositioning for Targeting Pf EMP1: Potential Therapeutics for Cerebral Malaria in Plasmodium falciparum

Kanika Verma, Kavita Patel, Ankit Yadav, Mohanraj Gopikrishnan, Rishu Sharma, Mradul Mohan, Ashutosh Mani iD, Praveen Kumar Bharti iD

Biotechnology and Applied Biochemistry · 2026-04 · 73 (2) · 488-512

DOI: 10.1002/bab.70040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, online erschienen am 13.08.2025. Verfasst von Kanika Verma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Epidemiology, National Institute of Malaria Research, Delhi, India. Hauptthemen laut MEDLINE: Plasmodium falciparum, Drug Repositioning, Protozoan Proteins, Antimalarials. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral malaria, a severe complication form of Plasmodium falciparum infection, remains a major global health challenge with limited treatment options. The National Programme currently recommends quinine‐ and artemisinin‐based combination therapy (ACT) for the treatment of severe malaria. However, the growing resistance to these treatments highlights the urgent need for alternative therapeutic strategies. A key factor in cerebral malaria pathophysiology is P. falciparum erythrocyte membrane protein 1 ( Pf EMP1), which facilitates the sequestration of infected red blood cells in the microvasculature. Targeting Pf EMP1 represents a promising approach for therapeutic interventions. This study uses a multi‐modal computational approach to identify FDA‐approved drugs that could be repurposed to target Pf EMP1. Among the top candidate molecules are Lumacaftor, Vilazodone, Tucatinib, Lenvatinib, and Hydrocortisone Cypionate, which exhibit favorable docking energies (−9.1 to −8.3 kcal/mol) and potential oral bioavailability, as determined by receptor‐based screening and absorbed, distributed, metabolized, and eliminated (ADME) analysis. Molecular dynamics simulations confirm stable interactions between these drug molecules and Pf EMP1, supported by favorable potential energy profiles and structural stability. Additionally, protein–ligand interaction analysis identifies key residues involved in drug binding, providing insights into their molecular effectiveness. Gibbs's free energy landscape analysis further reinforces the stability of these drug–protein complexes, underscoring their potential as therapeutic agents. These findings highlight the significant role of computational approaches in drug discovery and offer valuable insights into repurposing FDA‐approved drugs for cerebral malaria treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumDrug RepositioningProtozoan ProteinsAntimalarialsMalaria, CerebralMalaria, FalciparumHumansMolecular Dynamics SimulationMolecular Docking Simulation

Stichwörter der Autor:innen

Cerebral MalariaDrug RepurposingErythrocyte Membrane Protein 1 (EMP1)In SilicoPlasmodium falciparum

Substanzen

Protozoan ProteinsAntimalarialserythrocyte membrane protein 1, Plasmodium falciparum

Autor:innen und Institutionen

  • Department of Molecular Epidemiology, National Institute of Malaria Research, Delhi, India.
  • Department of Biotechnology, Motilal Nehru National Institute of Technology, Prayagraj (Allahabad), India.
  • Academy of Scientific and Innovative Research (AcSIR), CSIR-HRDC Campus Sector-19, Ghaziabad, Uttar Pradesh, India.
  • Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India.
  • Department of Immunology, ICMR-National Institute of Malaria Research, New Delhi, India.

ORCID-Profile: Ashutosh Mani, Praveen Kumar Bharti

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Verma, K., Patel, K., Yadav, A., Gopikrishnan, M., Sharma, R., Mohan, M., Mani, A., & Bharti, P. K. (2026). Computational Drug Repositioning for Targeting Pf EMP1: Potential Therapeutics for Cerebral Malaria in Plasmodium falciparum. Biotechnology and Applied Biochemistry, 73(2), 488-512. https://doi.org/10.1002/bab.70040

Vancouver

Verma K, Patel K, Yadav A, Gopikrishnan M, Sharma R, Mohan M, et al. Computational Drug Repositioning for Targeting Pf EMP1: Potential Therapeutics for Cerebral Malaria in Plasmodium falciparum. Biotechnology and Applied Biochemistry. 2026;73(2):488-512. doi:10.1002/bab.70040

BibTeX
@article{Verma2026,
  author = {Verma, Kanika and Patel, Kavita and Yadav, Ankit and Gopikrishnan, Mohanraj and Sharma, Rishu and Mohan, Mradul and Mani, Ashutosh and Bharti, Praveen Kumar},
  title = {Computational Drug Repositioning for Targeting Pf EMP1: Potential Therapeutics for Cerebral Malaria in Plasmodium falciparum},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2026},
  volume = {73},
  number = {2},
  pages = {488--512},
  doi = {10.1002/bab.70040}
}
Kostenlos starten →